Ignite Creation Date:
2025-12-24 @ 1:13 PM
Ignite Modification Date:
2026-03-01 @ 5:18 PM
Study NCT ID:
NCT04083495
Status:
RECRUITING
Last Update Posted:
2025-09-22
First Post:
2019-09-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
LCCC1904-ATL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None